Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma von Dimopoulos, Meletios A, Oriol, Albert, Nahi, Hareth, San-Miguel, Jesus, Bahlis, Nizar J, Usmani, Saad Z, Rabin, Neil, Orlowski, Robert Z, Komarnicki, Mieczyslaw, Suzuki, Kenshi, Plesner, Torben, Yoon, Sung-Soo, Ben Yehuda, Dina, Richardson, Paul G, Goldschmidt, Hartmut, Reece, Donna, Lisby, Steen, Khokhar, Nushmia Z, O’Rourke, Lisa, Chiu, Christopher, Qin, Xiang, Guckert, Mary, Ahmadi, Tahamtan, Moreau, Philippe

Volltext

Decrease in nickel sensitization in a Danish schoolgirl population with ears pierced after implementation of a nickel-exposure regulation von Jensen, C.S., Lisby, S., Baadsgaard, O., Vølund, A., Menné, T.

Volltext

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma von Lokhorst, Henk M, Plesner, Torben, Laubach, Jacob P, Nahi, Hareth, Gimsing, Peter, Hansson, Markus, Minnema, Monique C, Lassen, Ulrik, Krejcik, Jakub, Palumbo, Antonio, van de Donk, Niels W.C.J, Ahmadi, Tahamtan, Khan, Imran, Uhlar, Clarissa M, Wang, Jianping, Sasser, A. Kate, Losic, Nedjad, Lisby, Steen, Basse, Linda, Brun, Nikolai, Richardson, Paul G

Volltext

Transcriptional regulation of tumor necrosis factor-α in keratinocytes mediated by interleukin-1β and tumor necrosis factor-α von Lisby, S., Hauser, C.

Volltext

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial von Lonial, Sagar, Prof, Weiss, Brendan M, Prof, Usmani, Saad Z, Prof, Singhal, Seema, Prof, Chari, Ajai, Prof, Bahlis, Nizar J, Prof, Belch, Andrew, Prof, Krishnan, Amrita, Prof, Vescio, Robert A, Prof, Mateos, Maria Victoria, Prof, Mazumder, Amitabha, Prof, Orlowski, Robert Z, Prof, Sutherland, Heather J, Prof, Bladé, Joan, Prof, Scott, Emma C, Prof, Oriol, Albert, MD, Berdeja, Jesus, MD, Gharibo, Mecide, Prof, Stevens, Don A, MD, LeBlanc, Richard, Prof, Sebag, Michael, Prof, Callander, Natalie, Prof, Jakubowiak, Andrzej, Prof, White, Darrell, Prof, de la Rubia, Javier, Prof, Richardson, Paul G, Prof, Lisby, Steen, MD, Feng, Huaibao, PhD, Uhlar, Clarissa M, PhD, Khan, Imran, MD, Ahmadi, Tahamtan, MD, Voorhees, Peter M, Prof

Volltext

Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study von Wierda, William G., Padmanabhan, Swaminathan, Chan, Geoffrey W., Gupta, Ira V., Lisby, Steen, Österborg, Anders

Volltext

75P Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R)... von Mora, J., Chan, G.C., Morgenstern, D.A., Nysom, K., Bear, M., Dalby, L. Worsaae, Lisby, S., Kushner, B.H.

Volltext

74P Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) n... von Morgenstern, D.A., Mora, J., Chan, G.C., Nysom, K., Bear, M., Dalby, L. Worsaae, Lisby, S., Kushner, B.H.

Volltext

Nickel‐induced proliferation of both memory and naive T cells in patch test‐negative individuals von LISBY, S, HANSEN, L. H, MENNE, T, BAADSGAARD, O

Volltext

Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis von Allen, M H, Wakelin, S H, Holloway, D, Lisby, S, Baadsgaard, O, Barker, J N, McFadden, J P

Volltext

A phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors von Chenard-Poirier, M., Hong, D.S., Coleman, R., de Bono, J., Mau-Sorensen, M., Collins, D., Lisby, S., Basse, L., Lassen, U.

Volltext

A phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors von Chenard-Poirier, M., Hong, D.S., Coleman, R., de Bono, J., Mau-Sorensen, M., Collins, D., Lisby, S., Basse, L., Lassen, U.

Volltext

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial von Jensen, Jens U, Hein, Lars, Lundgren, Bettina, Bestle, Morten H, Mohr, Thomas T, Andersen, Mads H, Thornberg, Klaus J, Løken, Jesper, Steensen, Morten, Fox, Zoe, Tousi, Hamid, Søe-Jensen, Peter, Lauritsen, Anne Ø, Strange, Ditte, Petersen, Pernille L, Reiter, Nanna, Hestad, Søren, Thormar, Katrin, Fjeldborg, Paul, Larsen, Kim M, Drenck, Niels E, Østergaard, Christian, Kjær, Jesper, Grarup, Jesper, Lundgren, Jens D

Volltext

A phase IIa study of tisotumab vedotin (HuMax®-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer von Vergote, I., Dean, E., Lassen, U., de Bono, J., Drew, Y., Machiels, J-P., Nielsen, D., Arkenau, H-T., Forster, M., Jones, R., Slomovitz, B., Spicer, J., Johnson, M., Cornez, N., Gennigens, C., Fulton, B., Lisby, S., Basse, L., Coleman, R., Hong, D.S.

Volltext

Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation von Lisby, S, Ralfkiaer, E, Rothlein, R, Vejlsgaard, G L

Volltext

Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study von Plesner, Torben, Lokhorst, Henk, Gimsing, Peter, Nahi, Hareth, Lisby, Steen, Richardson, Paul G.

Volltext

Nickel-induced activation of T cells in individuals with negative patch test to nickel sulphate von LISBY, S, HANSEN, L. H, SKOV, L, MENNE, T, BAADSGAARD, O

Volltext

Experimental systemic contact dermatitis from nickel: a dose-response study von Jensen, Christian S., Menné, Torkil, Lisby, Steen, Kristiansen, Jesper, Veien, Niels K.

Volltext

Levels of Enzymatic Antioxidants Activities in Mononuclear Cells and Skin Reactivity to Sodium Dodecyl Sulphate von Camera, E., Lisby, S., Dell'Anna, M.L., Santucci, B., Paganelli, R., Baadsgaard, O., Picardo, M.

Volltext

UV-induced DNA damage in human keratinocytes: Quantitation and correlation with long-term survival von Lisby, Steen, Gniadecki, Robert, Wulf, Hans Christian

Volltext